Table 2.

Antimicrobial susceptibility profiles among the molecular types of MRSA isolates from pediatric patients.

Molecular type	Isolatesa (n)	CFZa (%)	LZDa (%)	CIPa (%)	DAa (%)	Ea (%)	SXTa (%)	MOFa (%)	FDa (%)	Va (%)	TETa (%)	Pa (%)	RDa (%)	LEVa (%)	AMPa (%)	GMa (%)	Q/Da (%)	TGCa (%)
ST59	36	100	0	0	94.4	97.2	0	0	0	0	36.1	100	0	0	100	0	0	0
ST398	9	100	0	0	88.9	88.9	0	0	0	0	11.1	100	0	0	100	0	0	0
ST88	7	100	0	14.3	57.1	71.4	14.3	14.3	0	0	42.9	100	14.3	14.3	100	14.3	0	0
ST5	6	100	0	33.3	83.3	83.3	50	16.7	0	0	33.3	100	0	33.3	100	16.7	0	0
ST630	6	100	0	16.7	83.3	83.3	0	16.7	0	0	16.7	100	16.7	16.7	100	16.7	0	0
ST7	3	100	0	33.3	66.7	66.7	66.7	0	0	0	33.3	100	0	0	100	0	0	0
ST45	2	100	0	0	50	50	0	0	0	0	0	100	0	0	100	0	0	0
ST9	2	100	0	100	100	100	100	0	0	0	100	100	0	0	100	0	0	0
ST338	2	100	0	0	100	100	0	0	0	0	100	100	0	0	100	0	0	0
ST72	1	100	0	0	0	0	0	0	0	0	0	100	0	0	100	0	0	0
ST950	1	100	0	0	0	0	0	0	0	0	0	100	0	0	100	0	0	0
ST30	1	100	0	0	0	0	0	0	0	0	0	100	0	0	100	0	0	0
ST6	1	100	0	0	100	100	0	0	0	0	0	100	0	0	100	0	0	0
ST20	1	100	0	0	0	0	0	0	0	0	0	100	0	0	100	0	0	0
ST121	1	100	0	0	0	0	0	0	0	0	100	100	0	0	100	0	0	0
ST1507	1	100	0	0	0	0	0	0	0	0	0	100	0	0	100	0	0	0
Total	80	100	0	8.75	80	82.5	10	3.75	0	0	32.5	100	2.5	5	100	3.75	0	0

^acefazolin (CFZ), linezolid (LZD), ciprofloxacin (CIP), clindamycin (DA), erythromycin (E), trimethoprim-sulfamethoxazole (SXT), moxifloxacin (MOF), nitrofurantoin (FD), vancomycin (V), tetracycline (TET), penicillin (P), rifampicin (RF), levofloxacin (LVX), ampicillin (AMP), gentamicin (GM), quinupristin/dalfopristin (Q/D) and tigecycline (TGC).